Medeca
The computed 12-month bankruptcy probability of Medeca is 0.5% (very low). The 2024 annual accounts show equity of €76k and a net result of €82k. Its solvency ranks better than 32% of 12430 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €76k |
| Net result | €82k |
| Better than sector | 32% |
| Active | 3 yrs |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 40.1% | 60.6% | |
| Net result | €82k | €31k | |
| Equity | €76k | €63k | |
| Gross operating margin | €113k | €52k | |
| Total assets | €189k | €124k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €112k |
| Net profit | €82k |
| Cash flow | €87k |
| Staff costs | - |
| Income taxes | €25k |
| Dividends | - |
| Total assets | €189k |
| Equity | €76k |
| Debt | €113k |
| of which ≤ 1y | €36k |
| of which > 1y | €77k |
| Working capital | €53k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 2.46 |
| Quick ratio | 2.46 |
| Working capital ratio | 28.1% |
| Solvency | 40.1% |
| Debt / equity | 1.49 |
| Long-term debt ratio | 1.01 |
| Interest coverage | 1084.37 |
| Gross margin | - |
| Net margin | - |
| ROA | 43.3% |
| ROE | 108.1% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €189k |
| Fixed assets | 21/28 | €100k |
| Tangible fixed assets | 22/27 | €100k |
| Current assets | 29/58 | €90k |
| Amounts receivable within one year | 40/41 | €28k |
| Cash & bank | 54/58 | €58k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €189k |
| Equity | 10/15 | €76k |
| Contributions / capital | 10/11 | €1k |
| Reserves | 13 | €75k |
| Amounts payable | 17/49 | €113k |
| Amounts payable after one year | 17 | €77k |
| Amounts payable within one year | 42/48 | €36k |
| Trade debts payable within one year | 44 | €1k |
| Income statement | ||
| Gross operating margin | 9900 | €113k |
| Operating result | 9901 | €107k |
| Financial charges | 65 | €104 |
| Result before taxes | 9903 | €107k |
| Income taxes | 67/77 | €25k |
| Net result for the period | 9904 | €82k |
| Result to be appropriated | 9905 | €82k |
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| Finvision Bedrijfsrevisoren AntwerpenCurrent Company auditor · represented by Karel Nijs |
- | 24-03-2025 → present |
| NACE primary | Head offices & management consulting(70200) |
| Legal form | Private limited company(610) |
| Incorporation | 16-03-2023 |
| Status | Active |
| Postal code | 8501 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 34016A0206/00L000 | Flanders | 638 m² | 1 · 112 m² | 12.3 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
09-04-2025 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2025-03-24",
"legal_form_change": false
},
"bedrijfsrevisor": {
"quote": "De heer Karel Nijs, revisor, vertegenwoordigende de besloten vennootschap \u201CFinvision Bedrijfsrevisoren Antwerpen\u201D, met zetel gevestigd te 2600 Antwerpen, Potvlietlaan 4, besluit zijn verslag met betrekking tot de inbreng in natura als volgt: ... waarvoor wij werden aangesteld bij opdrachtbrief van 4 maart 2025.",
"firm_kbo": null,
"firm_name": "Finvision Bedrijfsrevisoren Antwerpen",
"ibr_number": null,
"individual_name": "Karel Nijs"
},
"subject_company": {
"kbo": "0799.616.134",
"name_full": "MEDECA",
"legal_form": "BV"
},
"signature_regime": null,
"special_mandates": [
{
"quote": "Teneinde de nodige formaliteiten te vervullen bij de Kruispuntbank voor Ondernemingen, de ondernemingsloketten en bij de diensten van de btw, wordt volmacht gegeven aan de naamloze vennootschap \u201CFISCAAL BURO GHESQUIERE\u201D, gevestigd te 8000 Roeselaere, Meensesteenweg 401, met ondernemingsnummer 0432.861.312, en aan elke door haar aangestelde persoon.",
"holder_kbo": "0432.861.312",
"holder_name": "FISCAAL BURO GHESQUIERE",
"scope_categories": [
"KBO",
"tax",
"filing"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}01-07-2024 Registered office moved within Kortrijk
- Doornstraat 5, 8500 Kortrijk → Broelkaai 9, 8500 Kortrijk
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Kortrijk",
"region": null,
"street": "Broelkaai",
"country": "BE",
"postcode": "8500",
"box_number": "0021",
"street_number": "9"
},
"old_address": {
"city": "Kortrijk",
"region": null,
"street": "Doornstraat",
"country": "BE",
"postcode": "8500",
"box_number": "42",
"street_number": "5"
},
"effective_date": "2024-04-01",
"evidence_quote": "Bij beslissing van de bestuurder dd 01/04/2024 wordt de maatschappelijke zetel vanaf 1 april 2024 verplaatst van Doornstraat 5 bus 42, 8500 Kortrijk naar Broelkaai 9 bus 0021 app 2.3, 8500 Kortrijk."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0799.616.134",
"name_full": "MEDECA",
"legal_form": "BV"
}
}20-03-2023 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "8500 Kortrijk, Doornstraat 5 bus 0042",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1996-03-01",
"name": "DECLERCK Charles Rafa\u00EBl Walter",
"niss": null,
"address": "8500 Kortrijk, Doornstraat 5 bus 0042"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 50000,
"holder_person_name": "DECLERCK Charles Rafa\u00EBl Walter",
"is_subscriber_only": false,
"n_shares_subscribed": 50,
"amount_subscribed_eur": 50000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 50000,
"subject_company": {
"kbo": "0799.616.134",
"name_full": "Medeca",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2023-03-14",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Medeca |